Cargando…

Discovery of Novel Small Molecule Inhibitors of VEGF Expression in Tumor Cells Using a Cell-Based High Throughput Screening Platform

Current anti-VEGF (Vascular Endothelial Growth Factor A) therapies to treat various cancers indiscriminately block VEGF function in the patient resulting in the global loss of VEGF signaling which has been linked to dose-limiting toxicities as well as treatment failures due to acquired resistance. A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Liangxian, Weetall, Marla, Bombard, Jenelle, Qi, Hongyan, Arasu, Tamil, Lennox, William, Hedrick, Jean, Sheedy, Josephine, Risher, Nicole, Brooks, Peter C., Trifillis, Panayiota, Trotta, Christopher, Moon, Young-Choon, Babiak, John, Almstead, Neil G., Colacino, Joseph M., Davis, Thomas W., Peltz, Stuart W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5161367/ https://www.ncbi.nlm.nih.gov/pubmed/27992500 http://dx.doi.org/10.1371/journal.pone.0168366

Ejemplares similares

Phase 1 Study of Safety, Tolerability, and Pharmacokinetics of PTC299, an Inhibitor of Stress‐Regulated Protein Translation
por: Weetall, Marla, et al.
Publicado: (2016)

In vitro metabolism, reaction phenotyping, enzyme kinetics, CYP inhibition and induction potential of ataluren
por: Kong, Ronald, et al.
Publicado: (2020)

The nucleoside analog clitocine is a potent and efficacious readthrough agent
por: Friesen, Westley J., et al.
Publicado: (2017)

The minor gentamicin complex component, X2, is a potent premature stop codon readthrough molecule with therapeutic potential
por: Friesen, Westley J., et al.
Publicado: (2018)

Emvododstat, a Potent Dihydroorotate Dehydrogenase Inhibitor, Is Effective in Preclinical Models of Acute Myeloid Leukemia
por: Branstrom, Arthur, et al.
Publicado: (2022)

Small molecule splicing modifiers with systemic HTT-lowering activity
por: Bhattacharyya, Anuradha, et al.
Publicado: (2021)

Preclinical and Early Clinical Development of PTC596, a Novel Small-Molecule Tubulin-Binding Agent
por: Jernigan, Finith, et al.
Publicado: (2021)

The DHODH inhibitor PTC299 arrests SARS-CoV-2 replication and suppresses induction of inflammatory cytokines
por: Luban, Jeremy, et al.
Publicado: (2021)

Deflazacort versus prednisone/prednisolone for maintaining motor function and delaying loss of ambulation: A post HOC analysis from the ACT DMD trial
por: Shieh, Perry B., et al.
Publicado: (2018)

Longitudinal Evaluation of Working Memory in Duchenne Muscular Dystrophy
por: Thangarajh, Mathula, et al.
Publicado: (2020)

Discovery and Optimization of Indolyl-Containing 4-Hydroxy-2-Pyridone Type II DNA Topoisomerase Inhibitors Active against Multidrug Resistant Gram-negative Bacteria
por: Gerasyuto, Aleksey I., et al.
Publicado: (2018)

Correction to Discovery and Optimization of Indolyl-Containing 4-Hydroxy-2-pyridone Type II DNA Topoisomerase Inhibitors Active against Multidrug Resistant Gram-Negative Bacteria
por: Gerasyuto, Aleksey I., et al.
Publicado: (2018)

Efficacy of the novel tubulin polymerization inhibitor PTC‐028 for myelodysplastic syndrome
por: Zhong, Cheng, et al.
Publicado: (2020)

SMN Protein Can Be Reliably Measured in Whole Blood with an Electrochemiluminescence (ECL) Immunoassay: Implications for Clinical Trials
por: Zaworski, Phillip, et al.
Publicado: (2016)

Targeting of BMI-1 expression by the novel small molecule PTC596 in mantle cell lymphoma
por: Maeda, Aya, et al.
Publicado: (2018)

Natural History and Real‐World Data in Rare Diseases: Applications, Limitations, and Future Perspectives
por: Liu, Jing, et al.
Publicado: (2022)

Identification of benzazole compounds that induce HIV-1 transcription
por: Graci, Jason D., et al.
Publicado: (2017)

Evaluating longitudinal therapy effects via the North Star Ambulatory Assessment
por: McDonald, Craig M., et al.
Publicado: (2021)

Editorial: New therapeutics for soft tissue sarcomas
por: Weetall, Marla, et al.
Publicado: (2023)

The combination of the tubulin binding small molecule PTC596 and proteasome inhibitors suppresses the growth of myeloma cells
por: Nagai, Yurie, et al.
Publicado: (2021)

Use of Polycaprolactone Electrospun Nanofiber Mesh in a Face Mask
por: Khandaker, Morshed, et al.
Publicado: (2021)

Regulation of Synaptic Development by Astrocyte Signaling Factors and Their Emerging Roles in Substance Abuse
por: Walker, Christopher D., et al.
Publicado: (2020)

Gut dysbiosis in severe mental illness and chronic fatigue: a novel trans-diagnostic construct? A systematic review and meta-analysis
por: Safadi, Jenelle Marcelle, et al.
Publicado: (2021)

Pharmacokinetics, pharmacodynamics, and efficacy of a small-molecule SMN2 splicing modifier in mouse models of spinal muscular atrophy
por: Zhao, Xin, et al.
Publicado: (2016)

Ataluren suppresses a premature termination codon in an MPS I-H mouse
por: Wang, Dan, et al.
Publicado: (2022)

Aflibercept (VEGF Trap-eye): the newest anti-VEGF drug
por: Stewart, Michael W
Publicado: (2012)

MicroRNAs and senescence
por: Martinez, Ivan, et al.
Publicado: (2011)

Disease progression rates in ambulatory Duchenne muscular dystrophy by steroid type, patient age and functional status
por: McDonald, Craig M, et al.
Publicado: (2023)

Conference Report: THE SIXTH INTERNATIONAL MEETING ON CHEMICAL SENSORS Gaithersburg, MD July 22–25, 1996
por: Weetall, Howard H.
Publicado: (1997)

Beyond VEGF—The Weisenfeld Lecture
por: Miller, Joan W.
Publicado: (2016)

Low temperature heating and high temperature cooling: embedded water based surface heating and cooling systems
por: Babiak, Jan, et al.
Publicado: (2009)

VEGF Signaling in Neurological Disorders
por: Shim, Joon W., et al.
Publicado: (2018)

Placing and preserving priorities: projects, productivity, progress and people
por: Babiak, John
Publicado: (1998)

Ataluren delays loss of ambulation and respiratory decline in nonsense mutation Duchenne muscular dystrophy patients
por: McDonald, Craig M, et al.
Publicado: (2021)

An Increase in Vascular Endothelial Growth Factor (VEGF) and VEGF Soluble Receptor-1 (sFlt-1) Are Associated with Early Recurrent Spontaneous Abortion
por: Pang, Lihong, et al.
Publicado: (2013)

Neural progenitors find VEGF attractive
por: Dove, Alan W.
Publicado: (2003)

N-VEGF, the Autoregulatory Arm of VEGF-A
por: Katsman, Marina, et al.
Publicado: (2022)

VEGF(121)b and VEGF(165)b are weakly angiogenic isoforms of VEGF-A
por: Catena, Raúl, et al.
Publicado: (2010)

The Presence of VEGF Receptors on the Luminal Surface of Endothelial Cells Affects VEGF Distribution and VEGF Signaling
por: Stefanini, Marianne O., et al.
Publicado: (2009)

Overexpression of VEGF(121), but not VEGF(165) or FGF-1, improves oxygenation in MCF-7 breast tumours
por: Fenton, B M, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_v04lf29u7s6k9nv60eta06441s